ABPI analysis on NICE’s changes for evaluating new medicines: next steps

ABPI

31 January 2022 - NICE has published a new Manual, which sets out how the latest medicines and health technologies will be evaluated.

The ABPI’s Director of Value and Access Policy, Paul Catchpole, provides further commentary on the publication.

Read ABPI press release

Michael Wonder

Posted by:

Michael Wonder